Published Report - Veterinary CRO Market Size, Share, Trend and Analysis Report 2027

[Research Report] The veterinary CROs market was valued at US$ 710.81 million in 2018 and it is projected to reach US$ 1,440.15 million by 2027; it is expected to grow at a CAGR of 9.3% from 2019 to 2027.

Veterinary CROs are described as organizations offering services that support the veterinary drug discovery processes in veterinary drug companies. For example, some of the services veterinary CROs offer include market authorization support, regulatory support, support for clinical trials and toxicology studies. The growth of the Veterinary CROs Market is attributed to the increasing prevalence of veterinary diseases, rising animal expenditures and strategic initiatives by key players have been boosting the market over the years. However, dearth of skilled professionals is likely to have a negative impact on the growth of the market in the coming years. On the other hand, increasing number of vaccines and biosimilar development for animals is likely to provide growth opportunity for market players in the coming years.

The Veterinary CROs Market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Veterinary CROs Market

Market Insights

Growing Applications of Veterinary CROs in Healthcare to Drive Veterinary CROs Market Growth

The animals are playing important aspect in terms of clinical trials. Veterinary contract research organizations services protect and improve the health, efficiency and marketability of the livestock, animal products and veterinary biologics of our nation by preventing, regulating or removing animal diseases, and by tracking and promoting animal health and productivity. For instance, From January to April 2015, disease reports from countries in North and West Africa, the Middle East, East, South and Southeast Asia mainly included outbreaks of Foot and Mouth Disease (FMD) and H5N1 highly pathogenic avian influenza (HPAI), two major trans-boundary animal diseases that are of global economic concern. Disease like Lumpy Skin Disease (LSD), Foot-and-Mouth Disease, Hemorrhagic Septicemia, Black Quarter, Zoonotic disease events are leading to death of the animals, for the wellbeing of animals the veterinary CROs are taking steps for the clinical trial steps for the veterinary medicines.

Approved animal medicinal products help many farmers around the world avoid animal losses every day. These medicines are helpful for the farmers to take better care of their animals. The rising incidence of veterinary diseases is leading to drive the growth of veterinary CRO marketThe animal health sector is on a growth path, propelled by the rise of pet ownership and a global population hungry for meat and dairy products. The demand for animal husbandries or household pets is rising due to the rise in outsourcing activities by pharmaceutical companies. This trend has been seen as a plan to remain competitive and flexible in a market of exponential growth, sophisticated technologies, and an unstable economic environment. 

Companies generally outsource R&D tasks which include a broad range of activities such as, fundamental research to late-stage development: hit exploration and lead optimization, target validation, genetic engineering, assay development, safety and efficacy tests in animal models, and clinical trials which involve animals. In 2017, the total US pet industry spending was estimated to reach $69.36 billion, up from $66.75 billion in 2016. According to American Pet Products Association's 2019-2020 National Pet Owners Survey, the North American Pet Health Insurance Association (NAPHIA) announced that the U.S. and Canada pet health insurance market posted a combined gross paid premium of 1.42 billion dollars in 2018, up from 1.15 billion dollars in 2017. At the end of 2018, the total number of covered pets hit 2.43 million, up by more than 17 per cent from 2017. Therefore, rise in animal health care expenditure is expected to drive the veterinary CRO market during forecast period.

A rise in strategic initiatives by pharmaceutical companies has been witnessed during recent years. This trend has been seen as a plan to remain competitive and flexible in a market of exponential growth, collaboration, acquisition and partnerships, tests in animal models, and clinical trials which involve animal health. These merger and consolidation events typically introduce corporate cost-cutting measures that can be brutal on R&D budgets.

For instance, In August 2018, Charles River Acquired MPI Research premier non-clinical contract research organization (CRO) providing comprehensive testing services to biopharmaceutical and medical device companies. This acquisition will include Ocular toxicology, Infectious disease models for vaccine safety and efficacy studies for development of veterinary safety data assessment. In 2019, Charles River acquired Citoxlab is a premier, non-clinical contract research organization (CRO). Other than this the organizations have taken the initiative of product launch too, for instance, In June 2016, In June, the AVMA launched the AVMA Animal Health Research Database as a tool for researchers searching for animals to engage in clinical studies and for veterinarians and animal owners to discuss treatment options This acquisition will provide the drug discovery and development continuum of drug. This will lead to enhance the veterinary data safety business.

Service Type-Based Insights

In terms of service type, the Veterinary CROs Market is segmented into clinical trials, toxicology, market authorization and regulatory support, others. The clinical trials segment held a largest share of the market in 2019.

Veterinary CROs Market, by Service Type – 2018 and 2027

Application-Based Insights

Based on application, the Veterinary CROs Market is segmented into pet, livestock, wild. In 2019, the pet segment held the largest share of the market, by application.

Indication-Based Insights

In terms of indication, the Veterinary CROs Market is segmented into oncology, infectious diseases, neurology, others. In 2019, the oncology segment held the largest share of the market, by indication.

End User-Based Insights

In terms of end user, the Veterinary CROs Market is segmented into pharmaceutical companies, and others. In 2019, the biopharmaceutical segment held the largest share of the market, by end user.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Published Report - Veterinary CRO Market: Strategic Insights

Published Report - Veterinary CRO Market

• Market Size 2018
  US$ 710.81 Million
• Market Size 2027
  US$ 1,440.15 Million

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Service Type

• Clinical Trials
• Toxicology
• Market Authorization and Regulatory Support

Application

• Pet
• Livestock
• Wild

Indication

• Oncology
• Infectious Diseases
• Neurology

End-User

• Animal Husbandry

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

The Veterinary CROs Market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Veterinary CROs Market – by Service Type

• Clinical Trials
• Toxicology
• Market Authorization and Regulatory Support
• Others

Veterinary CROs Market – by Application

• Pet
• Livestock
• Wild

Veterinary CROs Market – by Indication

• Oncology
• Infectious Diseases
• Neurology
• Others

Veterinary CROs Market – by End User

• Biopharmaceutical Companies
• Others

Veterinary CROs Market – by Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA
• South America and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• Charles River
• KLIFOVET AG.
• Clinvet
• Löhlein & Wolf Vet Research
• Oncovet Clinical Research
• Ondax Scientific
• Triveritas
• Veterinary Research Management
• VetPharm, Inc.
• Vetspin Srl

Published Report - Veterinary CRO Market Report Scope